|

CT1182 injection Clinical Trials

1 actively recruiting trial

Pipeline

Early 1: 1

Top Sponsors

  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology1

Indications

  • B-cell Non Hodgkin Lymphoma (NHL)1
  • Follicular Lymphoma ( FL)1
  • DLBCL - Diffuse Large B Cell Lymphoma1
  • Cancer1

Other1 trial

A Clinical Study Exploring the Safety, Efficacy and Metabolic Kinetics of CT1182 Injection in Patients With Relapsed / Refractory Non Hodgkin Lymphoma
Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.